RxDoctor Payments DataLook up a doctor →

Molly Grassman, PA

Medical · Green Valley, AZNPI 1275807422

Payments from drug & device makers

$8,457in general payments, 2019–2025

Across 364 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • AstraZeneca$999
  • Johnson & Johnson$674
  • Pfizer$460
  • Incyte Corporation$460
  • GSK$308
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$7,80392%
  • Education$3564%
  • Other$2994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis35$1,000
AstraZeneca(2 entities)45$999
Johnson & Johnson31$674
Pfizer23$460
Incyte Corporation20$460
GSK18$308
Merck13$301
Sanofi11$274
Bristol Myers Squibb13$248
Regeneron Healthcare Solutions, Inc.8$240
Takeda Pharmaceuticals U.S.A., Inc.8$236
Pharmacosmos Therapeutics Inc.9$223
Daiichi Sankyo Inc.9$208
Astellas Pharma US Inc6$171
AbbVie7$169
Genentech USA, Inc.7$166
Bayer7$153
AVEO Pharmaceuticals, Inc.4$140
Beone Medicines USA, Inc.4$114
Stemline Therapeutics Inc.4$110
Seagen Inc.4$104
Genmab U.S., Inc.4$104
Mirati Therapeutics, Inc.4$94
Sobi, Inc4$88
Sanofi-aventis U.S. LLC1$85
Amgen4$83
Ipsen Biopharmaceuticals, Inc4$76
Gilead3$74
Sumitomo Pharma America, Inc.3$69
Tersera Therapeutics LLC2$68
Blueprint Medicines Corporation3$66
Rigel Pharmaceuticals, Inc.4$61
Lilly USA, LLC4$59
Coherus Oncology, Inc.2$58
Boehringer Ingelheim2$52
Exelixis Inc.2$50
Recordati_rare_diseases_inc.2$48
Deciphera Pharmaceuticals Inc.2$44
Legend Biotech USA Inc.2$43
EMD Serono, Inc.2$40
Caris MPI, Inc.2$39
Sun Pharmaceutical Industries Inc.2$36
Puma Biotechnology, Inc.2$36
Janssen Scientific Affairs, LLC1$28
Beigene USA, Inc.1$26
Menarini Silicon Biosystems, Inc.1$23
Jazz Pharmaceuticals Inc.1$23
Adaptive Biotechnologies Corporation1$22
Karyopharm Therapeutics Inc.1$22
Pharmaessentia USA Corporation1$20
ADC Therapeutics America, Inc.1$20
E.r. Squibb & Sons, L.L.C.1$19
Azurity Pharmaceuticals, Inc.1$18
Aadi Bioscience, Inc.2$18
Progenics Pharmaceuticals, Inc.1$18
Apellis Pharmaceuticals, Inc.1$17
Taiho Oncology, Inc.1$17
Teva Pharmaceuticals USA, Inc.1$15
G1 Therapeutics, Inc.1$13
Eisai Inc.1$12

How this compares

$8,457 in reported general payments places this provider in the 90th percentile of 748 medical providers in Arizona.

See all medical providers in Arizona

Medicare billing

Part B allowed, 2024
$118,317
Medicare patients
392
Services billed
1,225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NinlaroIxazomib Citrate13$195,468
OrgovyxRelugolix12$32,025
EliquisApixaban32$22,900
Anastrozole95$1,438
Letrozole61$1,193
Hydroxyurea29$877
Tamoxifen Citrate27$827
Gabapentin30$489
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$285
Warfarin Sodium38$249
Prednisone12$123
Zolpidem Tartrate14$102
Levothyroxine Sodium14$64
Acyclovir13$61
Lorazepam11$21

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Ninlaro$236$195,46813 claims
Sumitomo Pharma America, Inc.Orgovyx$69$32,02512 claims
PfizerEliquis$460$22,90032 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$15$6113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 748 medical providers in Arizona.

Other medical in Green Valley

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →